No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk

Breast Cancer Research and Treatment

Volumn 121, Issue 2, 2010, Pages 497-502

  Andonova, Irena E ^a,b,c   Justenhoven, Christina ^a,b   Winter, Stefan ^a,b   Hamann, Ute ^d   Baisch, Christian ^e   Rabstein, Sylvia ^f   Spickenheuer, Anne ^f   Harth, Volker ^f   Pesch, Beate ^f   Brüning, Thomas ^f   Ko, Yon Dschun ^e   Ganev, Varban ^g   Brauch, Hiltrud ^a,b  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e Johanniter Krankenhaus   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Breast cancer risk; Gsts; Polymorphisms

Indexed keywords

GLUTATHIONE TRANSFERASE A2; GLUTATHIONE TRANSFERASE M2; GLUTATHIONE TRANSFERASE O1; GLUTATHIONE TRANSFERASE O2; GLUTATHIONE TRANSFERASE Z1; ORAL CONTRACEPTIVE AGENT; TRANSFERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENOTYPE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENOPAUSE; OVARY CANCER; PRIORITY JOURNAL; SMOKING;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77953026567     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0589-5     Document Type: Article

References (23)

1. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, Fletcher O, Johnson N, dos Santos Silva I, Gibson L, Bojesen SE, Nordestgaard BG, Axelsson CK, Torres D, Hamann U, Justenhoven C, Brauch H, Chang-Claude J, Kropp S, Risch A, Wang-Gohrke S, Schurmann P, Bogdanova N, Dork T, Fagerholm R, Aaltonen K, Blomqvist C, Nevanlinna H, Seal S, Renwick A, Stratton MR, Rahman N, Sangrajrang S, Hughes D, Odefrey F, Brennan P, Spurdle AB, Chenevix-Trench G, Beesley J, Mannermaa A, Hartikainen J, Kataja V, Kosma VM, Couch FJ, Olson JE, Goode EL, Broeks A, Schmidt MK, Hogervorst FB, Veer LJ, Kang D, Yoo KY, Noh DY, Ahn SH, Wedren S, Hall P, Low YL, Liu J, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Sigurdson AJ, Stredrick DL, Alexander BH, Struewing JP, Pharoah PD, Easton DF (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39: 352-358 (Pubitemid 46328496)
2. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le ML, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Schurmann P, Dork T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Uitterlinden A, Rivadeneira F, Milne RL, Ribas G, GonzalezNeira A, Benitez J, Hopper JL, McCredie M, Southey M, Giles GG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093 (Pubitemid 47014426)
3. Cheng TC, Chen ST, Huang CS, Fu YP, Yu JC, Cheng CW, Wu PE, Shen CY (2005) Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113: 345-353
4. Raftogianis R, Creveling C, Weinshilboum R, Weisz J (2000) Estrogen metabolism by conjugation. J Natl Cancer Inst Monogr 27: 113-124
5. Salinas AE, Wong MG (1999) Glutathione S-transferases-a review. Curr Med Chem 6: 279-309
6. Hayes JD, Flanagan JU, Jowsey IR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45: 51-88
7. Egan KM, Cai Q, Shu XO, Jin F, Zhu TL, Dai Q, Gao YT, Zheng W (2004) Genetic polymorphisms in GSTM1, GSTP1, GSTT1, the risk for breast cancer: results from the Shanghai Breast Cancer Study, meta-analysis. Cancer Epidemiol Biomarkers Prev 13: 197-204 (Pubitemid 38222549)
8. Roodi N, Dupont WD, Moore JH, Pari FF (2004) Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk. Cancer Res 64: 1233-1236 (Pubitemid 38235587)
9. The MARIE-GENICA consortium on genetic susceptibility for menopausal hormone therapy related breast cancer risk genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women (2009) Breast Cancer Res Treat
10. Singh V, Parmar D, Singh MP (2008) Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility, treatment outcomes? Cancer Invest 26: 769-783
11. Johansson AS, Mannervik B (2001) Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J Biol Chem 276: 33061-33065
12. Wang L, Xu J, Ji C, Gu S, Lv Y, Li S, Xu Y, Xie Y, Mao Y (2005) Cloning expression, characterization of human glutathione S-transferase Omega 2. Int J Mol Med 16: 19-27
13. BaezS,Segura-AguilarJ,WiderstenM,JohanssonAS,MannervikB(1997) Glutathionetransferasescatalysethedetoxicationofoxidizedmetabolites(o-quinones) ofcatecholamines, mayserveasanantioxidantsystempreventingdegenerativecellularprocesses. BiochemJ324(Pt1):25-28(Pubitemid27229361)
14. Ni H, Yu XJ, Liu HJ, Lei W, Rengaraj D, Li XJ, Yang ZM (2009) Progesterone regulation of glutathione S-transferase Mu2 expression in mouse uterine luminal epithelium during preimplantation period. Fertil Steril 91: 2123-2130
15. TanguayRM,JorqueraR,PoudrierJ,St-LouisM(1996)Tyrosineitscatabolites: fromdisease-cancer.ActaBiochimPol43:209-216(Pubitemid126417423)
16. Blackshear PJ, Nairn AC, Kuo JF (1988) Protein kinases 1988: a current perspective. FASEB J 2: 2957-2969
17. Justenhoven C, Pierl CB, Haas S, Fischer HP, Baisch C, Hamann U, Harth V, Pesch B, Bruning T, Vollmert C, Illig T, Dippon J, Ko YD, Brauch H (2007) The CYP1B1-1358-GG genotype is associated with estrogen receptor-negative breast cancer. Breast Cancer Res Treat 111: 171-177
18. Pesch B, Ko Y, Brauch H, Hamann U, Harth V, Rabstein S, Pierl C, Fischer HP, Baisch C, Justenhoven C, Ranft U, Bruning T (2005) Factors modifying the association between hormonereplacement therapy, breast cancer risk. Eur J Epidemiol 20: 699-711 (Pubitemid 41266867)
19. JustenhovenC, Hamann U, Pesch B, Harth V, RabsteinS, Baisch C, Ko Y, Bruning T, Vollmert C, Illig T, Brauch H Breast cancer risk is linked with ERCC2 genotypes and a corresponding haplotype in a German population. Proceedings of the 96th Annual Meeting of the American Association of Cancer Research (AACR), page 960 (#4070), 2005 (2005) Woman in Cancer Research (WICR) Brigid G Leventhal Award 2005
20. Marahatta SB, Punyarit P, Bhudisawasdi V, Paupairoj A, Wongkham S, Petmitr S (2006) Polymorphism of glutathione Stransferase omega gene, risk of cancer. Cancer Lett 236: 276-281
21. Olsen A, Autrup H, Sorensen M, Overvad K, Tjonneland A (2008) Polymorphisms of glutathione S-transferase A1, O1, breast cancer among postmenopausal Danish women. Eur J Cancer Prev 17: 225-229 (Pubitemid 351549662)
22. Smith RA, Curran JE, Weinstein SR, Griffiths LR (2001) Investigation of glutathione S-transferase zeta, the development of sporadic breast cancer. Breast Cancer Res 3409-3411
23. Silva SN, Azevedo AP, Teixeira V, Pina JE, Rueff J, Gaspar JF (2009) The role of GSTA2 polymorphisms, haplotypes in breast cancer susceptibility: a case-control study in the Portuguese population. Oncol Rep 22: 593-598